You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hypoglycemic Agents

Showing 1 - 25 of 6,062
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetic Peripheral Neuropathy Trial in Wenzhou (hypoglycemic Agents(metformin), lipid-lowering drug(Statin))

Recruiting
  • Diabetic Peripheral Neuropathy
  • hypoglycemic Agents(metformin)
  • lipid-lowering drug(Statin)
  • Wenzhou, Zhejiang, China
    First Affiliated Hospital of Wenzhou Medical University
Sep 11, 2023

Response Rate in Patients With Advanced NSCLC on ICI

Recruiting
  • Non Small Cell Lung Cancer Metastatic
  • Diabetes Mellitus
  • Pembrolizumab
  • Assiut, Egypt
    Assiut university
Oct 20, 2023

Variable Effects of Anti-diabetics on Stress Hyperglycemia Ratio

Completed
  • Type 2 Diabetes
  • Sitagliptin/metformin ( 50/500mg) Oral Tablet
  • Empagliflozin/metformin(10/500mg) Oral Tablet
  • Baqubah, Diyala, Iraq
    College of Medicine, University of Diyala
Apr 7, 2023

Glucose Metabolism Disorders, Diabetes, Type 2, Hypoglycemic Agents Trial in Karachi (Empagliflozin 10 MG,

Recruiting
  • Glucose Metabolism Disorders
  • +3 more
  • Empagliflozin 10 MG
  • Insulin+Metformin+DPP4 inhibitor (DPP4I)
  • Karachi, Pakistan
    SINA Shireen Jinnah colony
Nov 28, 2023

Diabetic Retinopathy Trial in Cairo (Dapagliflozin 10mg Tab plus another oral hypoglycemic agent, Two oral hypoglycemic agents

Recruiting
  • Diabetic Retinopathy
  • Dapagliflozin 10mg Tab plus another oral hypoglycemic agent
  • Two oral hypoglycemic agents other than dapagliflozin
  • Cairo, Egypt
    Internal medicine and endocrinology department, Ain-shams univer
Jun 9, 2022

Diabetes Trial in Lahore (Oral Hypoglycemic Agents,Oral, Voreta, Voreta plus SunnyD PRO)

Not yet recruiting
  • Diabetes Mellitus
  • Oral Hypoglycemic Agents,Oral
  • +2 more
  • Lahore, Punjab, Pakistan
    University of Health Sciences
Jun 10, 2022

Diabetes, Type 2 Trial (Specific and educational guidelines on care for pathology (diabetes mellitus) according to each

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Specific and educational guidelines on care for pathology (diabetes mellitus) according to each profession involved in the research
  • (no location specified)
Jul 11, 2021

COVID 19, Coronavirus, Diabetes, Type 2 Trial in Be'er Ya'aqov, Petah tikva (Linagliptin 5 MG)

Terminated
  • COVID 19
  • +14 more
  • Linagliptin 5 MG
  • Be'er Ya'aqov, Israel
  • +2 more
May 28, 2021

Type2 Diabetes Trial in Beijing (Glucophage 500Mg Tablet, Acarbose Tablets, Sitagliptin tablet)

Unknown status
  • Type2 Diabetes Mellitus
  • Glucophage 500Mg Tablet
  • +5 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Feb 26, 2020

Resistance Training, Sport Performance, Muscle Recovery Trial in Porto Alegre (Resistance Training)

Unknown status
  • Resistance Training
  • +4 more
  • Resistance Training
  • Porto Alegre, Rio Grande Do Sul, Brazil
    Fundação Universitária de Cardiologia/ Instituto de Cardiologia
Jun 20, 2020

Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial in Japan (Dulaglutide, Biguanide (BG), Sulfonylurea (SU))

Active, not recruiting
  • Diabetes Mellitus
  • +6 more
  • Nagoya-shi, Aichi, Japan
  • +43 more
Jan 16, 2023

Patients Aged 65-85 (Both Included), Diagnosed of Mild Cognitive Impairment, Diagnosed of Type 2 Diabetes in Active Treatment

Completed
  • Patients Aged 65-85 (Both Included)
  • +2 more
  • Smart pillbox
  • Interactive digital platform
  • Granollers, Barcelona, Spain
  • +7 more
Aug 12, 2020

SGLT-2 Inhibitor in Patients With CAD and DM Undergoing PCI.

Recruiting
  • Coronary Artery Disease
  • Diabete Mellitus
  • SGLT2 inhibitor
  • Beijing, Beijing, China
    Beijing Anzhen Hospital
Apr 12, 2022

Acute Pancreatitis in Type 2 Diabetes Mellitus Treated With

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • empagliflozin
  • Oral non-incretin/non-sodium glucose co-transporter-2 inhibitors (SGLT2)-containing hypoglycaemic agents
  • Ingelheim am Rhein, Germany
    Boehringer Ingelheim International GmbH
Aug 19, 2022

Diabetes, Hypoglycemia Trial in Baton Rouge (hyperinsulinemic-hypoglycemic clamp, 13C-MRS procedure/Acetate infusion)

Recruiting
  • Diabetes
  • Hypoglycemia
  • hyperinsulinemic-hypoglycemic clamp
  • 13C-MRS procedure/Acetate infusion
  • Baton Rouge, Louisiana
    Pennington Biomedical Research Center
Aug 29, 2022

Type II Diabetes Trial (Hypoglycemic food group, Control group)

Not yet recruiting
  • Type II Diabetes
  • Hypoglycemic food group
  • Control group
  • (no location specified)
Feb 28, 2022

Hypoglycemia:Method Development Study

Completed
Has Results
  • Diabetes
  • Hyperinsulinemic-hypoglycemic clamp
  • Baton Rouge, Louisiana
    Pennington Biomedical Research Center
Jul 25, 2021

Hypoglycemic Drugs on Prognosis of Spinal Surgery in Diabetic

Recruiting
  • Diabetes Mellitus
  • Spinal Diseases
  • Hypoglycemic Drugs
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of Air Force Medical University (X
Jun 14, 2022

Type 2 Diabetes Trial in Beijing (GA guided anti-diabetic therapy adjustment, current guidelines to adjust treatment)

Recruiting
  • Type 2 Diabetes Mellitus
  • GA guided anti-diabetic therapy adjustment
  • current guidelines to adjust treatment
  • Beijing, China
  • +9 more
Jan 30, 2023

Type 2 Diabetes Trial in Nanjing (Mulberry Twig Alkaloid Tablet, Canagliflozin)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Nanjing, China
    Jianhua Ma
May 3, 2023

Mechanisms of Post-Bariatric Hypoglycemia

Recruiting
  • Hypoglycemia
  • Continuous Glucose Monitoring
  • +5 more
  • Boston, Massachusetts
    Joslin Diabetes Center
Apr 6, 2022

Diabetes, Hypoglycemia Trial (Controlled hypoglycemic state)

Not yet recruiting
  • Diabetes Mellitus
  • Hypoglycemia
  • Controlled hypoglycemic state
  • (no location specified)
Oct 3, 2022

Diabetes Type 2 Trial run by the NIDDK (Vitamin C)

Recruiting
  • Diabetes Type 2
  • Vitamin C
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

PreDiabetes Trial in Leon (Black bean protein hydrolysates (BPH), Commercial non-caloric beverage)

Completed
  • PreDiabetes
  • Black bean protein hydrolysates (BPH)
  • Commercial non-caloric beverage
  • Leon, Guanajuato, Mexico
    Universidad de Guanajuato
May 19, 2023

Community-based Primary Care Program Effects on Pharmacotherapy

Completed
  • Type 2 Diabetes
  • Hypertension
  • community-based primary care program
  • (no location specified)
Jul 30, 2023